share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  07/26 06:19
牛牛AI助理已提取核心訊息
Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on July 23, 2024. The transaction was executed on the open market at a price of $8.4774 per share, resulting in a total sale value of approximately $97,040.80. Following the sale, Borgeson's direct holdings in the company amount to 7,155,663 shares. The sale reflects a transaction in the company's common stock and is part of the normal course of trading activities.
Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on July 23, 2024. The transaction was executed on the open market at a price of $8.4774 per share, resulting in a total sale value of approximately $97,040.80. Following the sale, Borgeson's direct holdings in the company amount to 7,155,663 shares. The sale reflects a transaction in the company's common stock and is part of the normal course of trading activities.
Blake Borgeson，隸屬於Recursion Pharmaceuticals，Inc.[RXRX]，於2024年7月23日完成了對11447股A類普通股的出售。該交易以8.4774美元/股的價格在公開市場上進行，交易總價值約爲97040.80美元。出售後，Borgeson在公司的直接持股數爲7155663股。該出售反映了公司普通股的交易活動的正常情況。
Blake Borgeson，隸屬於Recursion Pharmaceuticals，Inc.[RXRX]，於2024年7月23日完成了對11447股A類普通股的出售。該交易以8.4774美元/股的價格在公開市場上進行，交易總價值約爲97040.80美元。出售後，Borgeson在公司的直接持股數爲7155663股。該出售反映了公司普通股的交易活動的正常情況。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間